Two-Stage Liver Surgery



Fig. 13.1
Indication of two-stage hepatectomy for colorectal liver metastases at Paul Brousse Hospital. (a) When the multinodular tumors are distributed unilobar and thought to be unresectable because of small future liver remnant (FLR), portal vein embolization (PVE) followed by one-stage hepatectomy is performed. (b) When the multinodular tumors are distributed bilobar but the largest tumor size is ≤30 mm and the tumor number in the FLR ≤3, standard one-stage hepatectomy with simultaneous local ablation therapy is performed. (c) When the multinodular tumors are distributed bilobar, the largest tumor size is >30 mm and the tumor number in the FLR >3, two-stage hepatectomy (TSH) is performed




Table 13.1
Demographics of studies of two-stage hepatectomy for colorectal liver metastases in the literature




































































































































































Study

Year

Country

Study periods

Total No. of surgically treated pts. for CLM

No. of pts. planned for TSH

Percentage of pts. planned for TSH (%)

Lygidakis et al.

2004

Greece

1991–2003

NR

62

NR

Garcea et al.

2004

UK

2001–2003

446

11

3

Pamecha et al.

2008

UK

1999–2005

280

14

5

Homayounfar et al.

2009

Germany

2005–2007

NR

24

NR

Tsai et al.

2010

USA

1994–2008

720

45

6

Karoui et al.

2010

France

2000–2008

NR

33

NR

Tsim et al.

2011

UK

2003–2006

131

38

29

Brouquet et al.

2011

USA

2002–2010

890

65

7

Narita et al.

2011

France

1996–2009

753

80

11

Stella et al.

2012

France

1995–2009

1042

56

5

Bowers et al.

2012

UK

2004–2010

NR

33

NR

Tanaka et al.

2012

Japan

2003–2011

232

24

10

Turrini et al.

2012

France

2000–2010

NR

48

NR

Muratore et al.

2012

Italy

1997–2009

653

47

7

Cardona et al.

2014

USA

2000–2009

1188

40

3

Giuliante et al.

2014

Italy

2002–2011

NR

130

NR

Faitot et al.

2015

France

2004–2010

NR

50

NR

Imai et al.

2015

France

2000–2012

845

125

15


When multiple publications were identified from the same institutions, only the most recent publication was included. CLM colorectal liver metastases, TSH two-stage hepatectomy, NR not reported




Concomitant Extrahepatic Disease


Previous studies reported the rate of concomitant extrahepatic disease to be ranged from 0 to 33% in patients who were planned for TSH (Table 13.2). At Paul Brousse Hospital, the presence of extrahepatic metastases is not considered a contraindication for hepatectomy if these are limited and resectable. When limited extrahepatic disease is located in the abdominal cavity (i.e. pedicular lymph node or peritoneal metastases), resection is performed at the time of first-stage hepatectomy. When extrahepatic disease is located outside the abdomen (such as lung metastasis), resection is usually performed 2–3 months after the second-stage hepatectomy, provided that the disease remains controlled by chemotherapy. In our recent study (2000–2012), concomitant extrahepatic disease was observed in 26% of the patients who were planned for TSH [12]. Among them, resection of concomitant extrahepatic disease was consequently achieved in 42%. Remaining concomitant extrahepatic disease was not resected mainly because of disease recurrence after second-stage hepatectomy or in cases of TSH failure. In our treatment strategy, the presence of extrahepatic disease was neither a predictive factor of TSH failure nor a prognostic factor of survival after TSH (unpublished data). What is crucial however, is to envisage resection of concomitant extrahepatic disease when the disease is controlled by chemotherapy.


Table 13.2
Perioperative features at first-stage hepatectomy











































































































































































































 
Concomitant extrahepatic disease (%)

Preoperative chemotherapy (%)

Simultaneous resection of primary tumor (%)

Major resection (%)

Concomitant use of local ablation therapy (%)

Intraoperative PVE/PVL (%)

Morbidity (%)

Mortality (%)

Lygidakis et al.

NR

NR

100

0

100

100

11

0

Garcea et al.

0

100

0

28

0

NR

NR

0

Pamecha et al.

0

100

0

14

0

0

0

0

Homayounfar et al.

4

75

0

0

29.2

100

13

0

Tsai et al.

7

71

49

25

23

73

26

4

Karoui et al.

12

61

100

0

15

52

21

0

Tsim et al.

0

97

0

NR

0

0

11

0

Brouquet et al.

0

100

29

3

3

0

25

0

Narita et al.

14

84

31

0

32

4

14

0

Stella et al.

6

96

49

4

76

61

37

0

Bowers et al.

0

85

31

23

9

3

23

0

Tanaka et al.

33

100

NR

5

0

86

29

0

Turrini et al.

0

100

37

0

67

0

10

0

Muratore et al.

26

79

0

4

0

23

19

0

Cardona et al.

0

100

100

2

9

9

14

0

Giuliante et al.

26

87

55

3

4

52

17

0

Faitot et al.

10

90

NR

NR

38

88

18a

2

Imai et al.

26

98

30

2

10

76

14a

1


aMajor complication (Clavien ≥ III)

PVE portal vein embolization, PVL portal vein ligation, NR not reported


Surgical Procedures of TSH



First-Stage Hepatectomy


At Paul Brousse Hospital, during the first-stage hepatectomy, either the most invaded hemiliver (usually the right) is resected, or, in most cases, the less-invaded liver lobe (FLR) is cleared of its metastases [10, 12, 13]. In the literature, limited hepatectomy (<3 segments) was mainly performed during first-stage hepatectomy (Fig. 13.2). Clearance is generally obtained by non-anatomical resection (Fig. 13.2a), and local ablation therapy such as cryotherapy and radiofrequency ablation (RFA), is only used in combination with hepatectomy for the treatment of unresectable tumors deeply located in the FLR with the purpose of sparing liver parenchyma of the FLR. Portal vein ligation (PVL)/PVE is routinely performed intraoperatively during the first-stage. Previous studies reported that stimulation of liver hypertrophy could also accelerate intrahepatic tumor progression after PVE [1417]. From this aspect, what is essential during first-stage hepatectomy is that all tumors in the FLR should be removed to avoid tumor regrowth, leading to the failure to proceed to second-stage procedure.

A331430_1_En_13_Fig2_HTML.jpg


Fig. 13.2
Procedure of two-stage hepatectomy. (a) During the first-stage hepatectomy, in most cases, the less-invaded liver lobe is cleared of its metastases, usually by non-anatomical resection. (b) Ligation of right portal vein. (c) Embolization by dehydrated ethanol. For the safety of second-stage hepatectomy, portal vein ligation and embolization is routinely performed during first-stage hepatectomy


Portal Vein Ligation/Embolization


At Paul Brousse Hospital, for the safety of second-stage hepatectomy, PVE using dehydrated ethanol in combination with ligation is routinely performed during first-stage hepatectomy (about 82%) (Fig. 13.2b, c) [12]. If PVL/PVE is not performed during first-stage, percutaneous PVE is added after first-stage (about 18%). The volume of FLR is evaluated by volumetric computed tomography (CT) analysis 4–6 weeks later. Whether PVL/PVE is performed during or after first-stage hepatectomy seems to depend on institutions (Tables 13.2 and 13.3).


Table 13.3
Perioperative features at second-stage hepatectomy































































































 
Interval duration (days)

Interval PVE (%)

Interval chemotherapy (%)

Major hepate ctomy (≥3 segments) (%)

Concomitant use of local ablation therapy (%)

Morbidity (%)

Mortality (%)

Lygidakis et al.

40

0

100

77

0

11

3

Garcea et al.

150

NR

0

78

0

33

0

Pamecha et al.

210

35.7

100

73

0

27

0

Homayounfar et al.

42

0

0

73

11

58

5

Tsai et al.

135

4

62

80

17

26

6

Karoui et al.

111

15

76

92

4

32

4

Tsim et al.

NR

95

13

NR

0

33

0

Brouquet et al.

32

70

19

85

0

49

0

Narita et al.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 6, 2017 | Posted by in GASTROENTEROLOGY | Comments Off on Two-Stage Liver Surgery

Full access? Get Clinical Tree

Get Clinical Tree app for offline access